CAD case, n=55 | CAD control, n=110 | Stroke case, n=56 | Stroke control, n=112 | |
Severe CHD | ||||
(1) TGA | 3 (6%) | 6 (6%) | 4 (7%) | 8 (7%) |
(2) Other severe | 1 (2%) | 2 (2%) | 5 (9%) | 10 (9%) |
Moderate CHD | ||||
(3) TOF | 6 (11%) | 12 (11%) | 7 (13%) | 14 (13%) |
(4) Coarctation of the aorta | 6 (11%) | 12 (11%) | 8 (14%) | 16 (14%) |
(5) Marfan syndrome | 6 (11%) | 12 (11%) | 2 (4%) | 4 (4%) |
(6) Other moderate | 1 (2%) | 2 (2%) | 2 (4%) | 4 (4%) |
Simple CHD | ||||
(7) Aortic valve defects | 10 (18%) | 20 (18%) | 11 (20%) | 22 (20%) |
(8) Simple shunt lesions | 18 (33%) | 36 (33%) | 14 (25%) | 28 (25%) |
(9) Other mild | 4 (7%) | 8 (7%) | 3 (5%) | 6 (5%) |
Male gender | 44 (80%) | 88 (80%) | 26 (46%) | 52 (46%) |
Age (years) | 55±12 | 54±12 | 47±15 | 47±16 |
CAD, coronary artery disease; CHD, congenital heart disease; iCVA, ischaemic cerebrovascular accident;TGA, transposition of the great arteries; TOF, tetralogy of Fallot.